Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
ATTO	ATTOVIA THERAPEUTICS INC	$671.99M	N/A	N/A	N/A	N/A	-0.11	9.39	N/A	N/A	N/A
ABCL	ABCELLERA BIOLOGICS INC	$3.87B	-17.50%	-12.40%	-15.97%	-16.80%	0.46	12.77	100.00%	-248.80%	-302.80%
BSEM	BIOSTEM TECHNOLOGIES INC	$40.16M	N/A	N/A	N/A	N/A	0.77	0.98	N/A	N/A	N/A
CLDX	CELLDEX THERAPEUTICS INC	$2.22B	-52.40%	-47.60%	-41.68%	-58.10%	0.10	11.82	100.00%	-190,220.90%	-190,220.89%
MNPR	MONOPAR THERAPEUTICS	$483.81M	-13.10%	-12.80%	-13.63%	-28.40%	0.03	33.56	N/A	N/A	N/A
LEXX	LEXARIA BIOSCIENCE CORP	$4.63M	-160.70%	-143.90%	-175.71%	-1,299.10%	0.09	10.60	100.00%	-3,985.60%	-3,983.31%
BHVN	BIOHAVEN LTD	$1.72B	-1,328.90%	-138.30%	-190.08%	-155.20%	29.33	4.73	N/A	N/A	N/A
EQ	EQUILLIUM INC	$83.70M	-41.20%	-38.30%	-32.05%	2,525.80%	0.05	23.40	N/A	N/A	N/A
SGMT	SAGIMET BIOSCIENCES INC	$496.03M	-32.00%	-30.60%	-18.25%	-58.30%	0.03	45.03	N/A	N/A	N/A
AVTX	AVALO THERAPEUTICS INC	$644.10M	-58.00%	-48.20%	-21.33%	-68.70%	0.09	19.31	100.00%	-170,055.90%	-169,766.10%
ENGN	ENGENE THERAPEUTICS INC	$109.24M	-55.80%	-45.20%	-48.94%	-49.90%	0.25	10.21	N/A	N/A	N/A
SENS	SENSEONICS HOLDINGS INC	$471.64M	-165.80%	-80.20%	-68.50%	-86.00%	0.96	6.75	54.90%	-225.30%	-214.69%
TMDX	TRANSMEDICS GROUP INC	$2.74B	33.00%	12.30%	6.87%	7.00%	1.83	6.63	58.70%	22.70%	14.03%
OTLK	OUTLOOK THERAPEUTICS INC	$137.30M	N/A	-288.00%	2,502.35%	43,243.80%	-3.52	0.81	195.60%	5,253.50%	5,364.40%
GANX	GAIN THERAPEUTICS INC	$61.54M	-161.60%	-118.40%	-160.16%	1,956.40%	0.37	4.36	N/A	N/A	N/A
FLGT	FULGENT GENETICS INC	$579.47M	-7.90%	-7.20%	-8.96%	-10.10%	0.09	6.34	35.60%	-26.00%	-28.15%
SRXH	SRX GLOBAL INC	$27.76M	-83.30%	-61.40%	-22.97%	-198.50%	0.02	27.55	22.20%	138.10%	131.85%
PRCT	PROCEPT BIOROBOTICS CORP	$1.09B	-30.60%	-22.10%	-28.45%	-47.50%	0.41	6.55	64.20%	-32.50%	-35.01%
AVLN	AVALYN PHARMA INC	$1.05B	N/A	N/A	N/A	N/A	0.07	33.12	N/A	N/A	N/A
AEMD	AETHLON MEDICAL INC	$3.97M	-123.10%	-99.30%	-133.15%	-2,420.30%	0.20	5.42	N/A	N/A	N/A
ELTX	ELICIO THERAPEUTICS INC	$46.52M	-1,266.40%	-139.90%	-163.87%	-252.00%	2.95	2.77	N/A	N/A	N/A
CTMX	CYTOMX THERAPEUTICS INC	$506.62M	-39.90%	-31.50%	-23.27%	-39.50%	0.26	9.36	100.00%	-451.60%	-433.95%
KOD	KODIAK SCIENCES INC	$5.76B	-273.20%	-85.50%	-118.60%	-99.80%	3.20	2.49	N/A	N/A	N/A
MAIA	MAIA BIOTECHNOLOGY INC	$70.56M	-211.10%	-126.30%	-122.12%	430.90%	0.37	4.51	N/A	N/A	N/A
IXHL	INCANNEX HEALTHCARE INC	$36.50M	-26.30%	-25.20%	-27.00%	-473.00%	0.08	48.81	N/A	N/A	N/A
ZBIO	ZENAS BIOPHARMA INC	$1.64B	-189.70%	-89.90%	-72.33%	-118.20%	1.84	9.93	100.00%	-48,438.40%	-45,990.40%
RVMD	REVOLUTION MEDICINES INC	$40.39B	-96.40%	-63.20%	-43.06%	-66.30%	0.66	11.38	N/A	N/A	N/A
LABT	LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC	$1.64M	N/A	-443.70%	-166.77%	-29,672.30%	0.15	7.70	N/A	N/A	N/A
ARTL	ARTELO BIOSCIENCES INC	$1.52M	-519.10%	-194.60%	-246.52%	388.90%	0.29	3.00	N/A	N/A	N/A
MYGN	MYRIAD GENETICS INC	$390.25M	-32.60%	-16.40%	-18.77%	-22.20%	1.10	2.21	68.80%	-14.00%	-11.83%
AMLX	AMYLYX PHARMACEUTICALS INC	$2.99B	-52.90%	-48.50%	-62.46%	-133.20%	0.11	12.12	N/A	N/A	N/A
AGMB	AGOMAB THERAPEUTICS NV	$429.37M	N/A	N/A	N/A	N/A	0.10	12.88	N/A	N/A	N/A
ALMS	ALUMIS INC	$849.10M	-103.00%	-82.30%	-90.98%	-113.90%	0.24	6.74	100.00%	-5,933.50%	-5,957.20%
VYGR	VOYAGER THERAPEUTICS INC	$132.48M	-57.90%	-45.00%	-59.43%	-53.80%	0.28	7.51	100.00%	-312.60%	-312.26%
PTHS	PELTHOS THERAPEUTICS INC	$77.68M	-264.30%	-64.00%	-81.95%	-135.70%	-92.51	1.98	78.60%	-199.50%	-199.47%
AARD	AARDVARK THERAPEUTICS INC	$88.41M	-71.50%	-64.90%	-93.09%	-163.90%	0.09	12.63	N/A	N/A	N/A
PACB	PACIFIC BIOSCIENCES OF CALIFORNIA INC	$637.20M	-4,961.70%	-16.80%	-18.04%	-12.00%	-23.64	4.92	36.40%	-82.50%	-77.37%
FOCL	EDAP TMS SA	$157.62M	-323.70%	-55.90%	-76.14%	-68.70%	-24.12	1.60	45.80%	-55.80%	-39.90%
LUCD	LUCID DIAGNOSTICS INC	$123.17M	-503.00%	-156.00%	-457.05%	-1,674.50%	2.56	1.33	-21.70%	-1,193.90%	-959.43%
ALT	ALTIMMUNE INC	$472.68M	-31.40%	-27.00%	-17.14%	-30.40%	0.11	26.78	100.00%	-296,000.00%	-284,593.55%
NRXP	NRX PHARMACEUTICALS INC	$116.90M	N/A	-126.90%	-7,809.79%	89.60%	-201.94	0.86	46.60%	-691.80%	-658.10%
NYXH	NYXOAH SA	$55.07M	-175.30%	-80.30%	-62.27%	-184.10%	1.03	2.38	60.20%	-443.20%	-348.41%
AORT	ARTIVION INC	$1.04B	-0.70%	-0.30%	2.75%	4.40%	1.41	3.47	64.40%	-0.70%	5.62%
ANRO	ALTO NEUROSCIENCE INC	$866.86M	-46.50%	-39.10%	-34.53%	-404.10%	0.16	14.85	N/A	N/A	N/A
PMI	PICARD MEDICAL INC	$35.85M	-931.20%	-198.30%	-1,484.67%	-1,743.20%	4.34	1.02	18.60%	-444.30%	-404.40%
NMAD	NOMAD POWER SOLUTIONS INC	$68.91M	-75.10%	-62.70%	-34.30%	-113.60%	0.07	12.87	N/A	N/A	N/A
SVRA	SAVARA INC	$982.10M	-90.30%	-69.00%	-79.82%	-76.60%	0.34	10.13	N/A	N/A	N/A
ELVN	ENLIVEN THERAPEUTICS INC	$2.89B	-18.50%	-18.10%	-11.82%	-23.30%	0.02	64.07	N/A	N/A	N/A
ODTX	ODYSSEY THERAPEUTICS INC	$828.53M	N/A	N/A	N/A	N/A	0.15	11.36	N/A	N/A	N/A
TSHA	TAYSHA GENE THERAPIES INC	$1.17B	-56.20%	-41.80%	-33.66%	-260.20%	0.22	17.77	100.00%	-2,728.00%	-2,727.27%
IMRX	IMMUNEERING CORP	$230.32M	-27.20%	-25.70%	-29.53%	-57.40%	0.06	19.47	N/A	N/A	N/A
QURE	UNIQURE NV	$1.48B	-112.00%	-29.00%	-20.57%	-19.90%	2.04	10.01	92.50%	-1,350.70%	-993.35%
ORKA	ORUKA THERAPEUTICS INC	$5.18B	-20.80%	-20.10%	-11.90%	-25.10%	0.02	38.51	N/A	N/A	N/A
CYH	COMMUNITY HEALTH SYSTEMS INC	$421.62M	-17.60%	1.90%	11.43%	6.50%	-9.37	1.53	85.40%	2.10%	9.69%
MAZE	MAZE THERAPEUTICS INC	$1.48B	-34.90%	-30.20%	-25.91%	-56.10%	0.17	18.31	100.00%	-667.90%	-658.97%
SPRY	ARS PHARMACEUTICALS INC	$402.76M	-256.70%	-69.60%	-110.26%	-54.50%	18.94	3.48	71.40%	-184.20%	-177.88%
BNTC	BENITEC BIOPHARMA INC	$301.04M	-28.40%	-27.80%	-25.69%	7,762.40%	0.03	34.00	N/A	N/A	N/A
BCTX	BRIACELL THERAPEUTICS CORP	$32.28M	-155.10%	-130.60%	-134.00%	-411.10%	0.16	7.07	N/A	N/A	N/A
FRNM	FREENOME INC	$1.35B	N/A	-306.80%	-77.99%	-309.10%	-0.30	1.89	93.10%	-818.90%	-802.05%
ORIC	ORIC PHARMACEUTICALS INC	$1.17B	-35.40%	-33.40%	-36.56%	-39.70%	0.06	13.19	N/A	N/A	N/A
DFTX	DEFINIUM THERAPEUTICS INC	$4.62B	-85.20%	-64.60%	-36.49%	-198.20%	0.21	6.95	N/A	N/A	N/A
DBVT	DBV TECHNOLOGIES SA	$534.69M	-119.30%	-84.40%	-103.74%	3,499.70%	0.39	3.72	100.00%	-3,506.50%	-3,491.11%
ABOS	ACUMEN PHARMACEUTICALS INC	$131.26M	-136.30%	-81.60%	-145.64%	-135.20%	1.03	2.47	N/A	N/A	N/A
EVMN	EVOMMUNE INC	$213.40M	-62.60%	-40.50%	-33.28%	-53.20%	0.09	11.68	100.00%	-946.70%	-946.68%
ALDX	ALDEYRA THERAPEUTICS INC	$54.29M	-53.10%	-34.90%	-57.10%	452.20%	0.26	4.91	N/A	N/A	N/A
RZLT	REZOLUTE INC	$445.89M	-63.00%	-57.90%	-76.49%	-67.70%	0.12	9.68	N/A	N/A	N/A
PYXS	PYXIS ONCOLOGY INC	$154.30M	-215.20%	-112.20%	-319.24%	-141.10%	3.80	1.34	78.40%	-803.80%	-793.84%
SCLX	SCILEX HOLDING CO	$24.46M	N/A	-151.00%	168.05%	330.20%	-1.83	0.07	55.50%	-1,418.50%	-1,375.29%
IRLA	IRULYA THERAPEUTICS INC	$28.35M	N/A	-104.50%	-81.94%	-1,714.50%	-0.44	14.52	N/A	N/A	N/A
GNLX	GENELUX CORP	$114.02M	-205.80%	-138.80%	-195.51%	-255.60%	0.63	2.39	N/A	N/A	N/A
AURA	AURA BIOSCIENCES INC	$650.23M	-73.20%	-62.00%	-39.85%	-90.70%	0.10	16.82	N/A	N/A	N/A
FRMM	FORUM MARKETS INC	$55.30M	-218.40%	-127.30%	-345.50%	-133.90%	0.24	2.69	91.00%	-4,971.70%	-4,931.88%
CADL	CANDEL THERAPEUTICS INC	$709.33M	-89.40%	-56.30%	-42.88%	-240.10%	0.65	16.09	N/A	N/A	N/A
LXEO	LEXEO THERAPEUTICS INC	$224.81M	-41.90%	-38.00%	-36.45%	-57.90%	0.08	13.89	N/A	N/A	N/A
RAPP	RAPPORT THERAPEUTICS INC	$1.39B	-29.00%	-27.40%	-31.86%	-36.00%	0.09	15.72	100.00%	-685.80%	-685.80%
IBIO	IBIO INC	$50.29M	-47.90%	-42.20%	-37.76%	-112.80%	0.16	7.85	100.00%	-33,044.00%	-32,991.00%
STOK	STOKE THERAPEUTICS INC	$1.45B	-59.40%	-51.50%	-63.39%	-89.30%	0.14	7.69	100.00%	-753.60%	-808.90%
CDXS	CODEXIS INC	$144.55M	-74.40%	-23.60%	-26.07%	-17.70%	2.64	3.06	87.00%	-39.60%	-32.41%
KYTX	KYVERNA THERAPEUTICS INC	$356.84M	-81.90%	-63.70%	-76.56%	-84.80%	0.33	9.06	N/A	N/A	N/A
LFMD	LIFEMD INC	$119.06M	-24.50%	-4.40%	3.92%	-2.90%	6.52	0.90	87.90%	-1.40%	0.25%
FULC	FULCRUM THERAPEUTICS INC	$280.77M	-28.50%	-27.20%	-27.10%	-38.50%	0.04	31.35	N/A	N/A	N/A
OSTX	OS THERAPIES INC	$66.88M	N/A	-477.40%	365.68%	326.00%	-1.74	0.18	N/A	N/A	N/A
ZURA	ZURA BIO LTD	$405.36M	-74.70%	-66.50%	-43.12%	752.30%	0.08	12.90	N/A	N/A	N/A
TARA	PROTARA THERAPEUTICS INC	$154.83M	-41.70%	-38.80%	-43.01%	-46.80%	0.09	10.97	N/A	N/A	N/A
SRRK	SCHOLAR ROCK HOLDING CORP	$4.93B	-160.20%	-87.20%	-88.17%	-209.20%	1.06	7.02	N/A	N/A	N/A
TRVI	TREVI THERAPEUTICS INC	$1.75B	-23.60%	-22.60%	-15.90%	-28.40%	0.03	37.28	N/A	N/A	N/A
NBP	NOVABRIDGE BIOSCIENCES	$149.71M	-37.90%	-34.40%	-36.71%	-265.40%	0.15	7.64	N/A	N/A	N/A
FDMT	4D MOLECULAR THERAPEUTICS INC	$682.82M	-41.30%	-35.90%	-40.27%	-42.80%	0.21	8.03	100.00%	-194.70%	-194.74%
ABEO	ABEONA THERAPEUTICS INC	$258.47M	-41.70%	-30.40%	-48.47%	-56.20%	0.40	6.64	67.10%	-246.40%	-293.83%
CRVS	CORVUS PHARMACEUTICALS INC	$791.58M	-36.10%	-33.60%	-23.99%	-40.30%	0.06	16.16	N/A	N/A	N/A
MODD	MODULAR MEDICAL INC	$17.44M	-292.10%	-222.80%	-260.35%	-479.00%	0.14	3.25	N/A	N/A	N/A
PHVS	PHARVARIS NV	$2.11B	-61.00%	-55.60%	N/A	-1,530.20%	0.09	N/A	N/A	N/A	N/A
GCTK	GLUCOTRACK INC	$782.83k	-2,135.50%	-290.20%	1,059.88%	1,555.90%	-1.86	0.46	N/A	N/A	N/A
LXRX	LEXICON PHARMACEUTICALS INC	$716.38M	-40.40%	-26.90%	-22.41%	-33.70%	0.43	13.37	99.10%	-147.40%	-127.16%
VERU	VERU INC	$37.34M	-45.90%	-34.60%	-44.08%	-365.60%	0.31	4.42	N/A	N/A	N/A
QCLS	Q/C TECHNOLOGIES INC	$4.47M	-100.70%	-52.60%	-85.83%	-245.20%	0.24	3.29	N/A	N/A	N/A
PCVX	VAXCYTE INC	$9.94B	-37.60%	-33.60%	-37.12%	-37.80%	0.14	5.72	N/A	N/A	N/A
AMIX	AUTONOMIX MEDICAL INC	$2.92M	-267.70%	-216.70%	-509.36%	1,690.00%	0.26	4.85	N/A	N/A	N/A
CRDF	CARDIFF ONCOLOGY INC	$78.57M	-103.10%	-75.60%	-150.95%	-141.30%	0.41	3.30	100.00%	-7,889.00%	-7,884.06%
BCAX	BICARA THERAPEUTICS INC	$1.15B	-41.50%	-38.60%	-39.50%	-66.90%	0.09	11.59	N/A	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	605	-3.31%	-4.41%	-12.70%	-72.42%	14.11x	4.88x	-11.01%	-10.03%	-8.07%	+80.04%	Strong Buy
Diagnostics & Research	50	+0.10%	+0.57%	+9.91%	+27.17%	11.79x	4.71x	-29.33%	+5.36%	+11.40%	+2.64%	Buy
Drug Manufacturers - General	20	-1.75%	+0.62%	+1.14%	+24.37%	39.28x	7.83x	+23.62%	+10.74%	+19.12%	+25.37%	Buy
Drug Manufacturers - Specialty & Generic	75	-1.97%	-0.73%	-5.30%	-94.19%	-1.74x	2.35x	-1.68%	+1.60%	+7.12%	+194.41%	Buy
Healthcare Plans	10	-0.24%	+3.91%	-0.88%	+18.01%	55.82x	2.32x	+10.70%	+3.28%	+8.15%	+11.54%	Buy
Health Information Services	50	-0.34%	-0.87%	+0.40%	-44.85%	11.95x	4.03x	+7.12%	+4.01%	+9.09%	+17.05%	Buy
Medical Care Facilities	48	-0.09%	+1.43%	-0.27%	-53.67%	16.80x	5.73x	-42.74%	+7.27%	+14.52%	+13.50%	Buy
Medical Devices	132	-0.38%	+0.33%	-1.59%	-95.34%	22.66x	3.06x	-9.45%	+5.29%	+9.68%	+27.22%	Strong Buy
Medical Distribution	8	+0.84%	+3.87%	+3.55%	+23.59%	26.62x	-190.64x	-76.01%	+4.11%	+24.39%	+6.81%	Buy
Medical Instruments & Supplies	50	-0.46%	+1.98%	+2.84%	+3.00%	44.54x	3.37x	+8.63%	+7.24%	+11.01%	+14.77%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Oct 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the #1 top healthcare stock out of 1048 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Puma Biotechnology (NASDAQ:PBYI) is: Value: A, Growth: C, Momentum: A, Sentiment: C, Safety: C, Financials: A, and AI: B.

Puma Biotechnology (NASDAQ:PBYI) has a Due Diligence Score of 48, which is 21 points higher than the healthcare sector average of 27. It passed 15 out of 33 due diligence checks and has strong fundamentals. Puma Biotechnology has seen its stock return 91.3% over the past year, overperforming other healthcare stocks by 169 percentage points.

Puma Biotechnology has an average 1 year price target of $6.00, a downside of -40.71% from Puma Biotechnology's current stock price of $10.12.

Puma Biotechnology stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Puma Biotechnology, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Bausch Health Companies (NYSE:BHC)

Bausch Health Companies (NYSE:BHC) is the #2 top healthcare stock out of 1048 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Bausch Health Companies (NYSE:BHC) is: Value: A, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: C, and AI: C.

Bausch Health Companies (NYSE:BHC) has a Due Diligence Score of 6, which is -21 points lower than the healthcare sector average of 27. Although this number is below the industry average, our proven quant model rates BHC as a "A".It passed 2 out of 33 due diligence checks and has weak fundamentals. Bausch Health Companies has seen its stock lose -3.6% over the past year, overperforming other healthcare stocks by 74 percentage points.

Bausch Health Companies has an average 1 year price target of $9.00, an upside of 52.8% from Bausch Health Companies's current stock price of $5.89.

Bausch Health Companies stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Bausch Health Companies, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #3 top healthcare stock out of 1048 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: B, Growth: B, Momentum: B, Sentiment: C, Safety: B, Financials: A, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 48, which is 21 points higher than the healthcare sector average of 27. It passed 15 out of 33 due diligence checks and has strong fundamentals. Bioventus has seen its stock return 106.39% over the past year, overperforming other healthcare stocks by 184 percentage points.

Bioventus has an average 1 year price target of $16.00, an upside of 17.99% from Bioventus's current stock price of $13.56.

Bioventus stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Bioventus, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 79 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Conmed (NYSE:CNMD)

Conmed (NYSE:CNMD) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2.25%. Conmed's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Conmed's dividend has not shown consistent growth over the last 10 years.

Conmed's dividend payout ratio of 10.8% indicates that its dividend yield is sustainable for the long-term.

2. Cumberland Pharmaceuticals (NASDAQ:CPIX)

Cumberland Pharmaceuticals (NASDAQ:CPIX) has an annual dividend yield of 20.92%, which is 19 percentage points higher than the healthcare sector average of 2.25%.

Cumberland Pharmaceuticals's dividend payout ratio of -411% indicates that its high dividend yield might not be sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 11.52%, which is 9 percentage points higher than the healthcare sector average of 2.25%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 207.9% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -1.35% in the last day, and down -0.79% over the last week. Syndax Pharmaceuticals was the among the top losers in the healthcare sector, dropping -15.71% yesterday.

Syndax Pharmaceuticals shares are trading lower after the company announced that the MAXPIRe Phase 2 trial of axatilimab in idiopathic pulmonary fibrosis did not meet its primary endpoint of the annualized rate of decline in forced vital capacity.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 86, which is 69 points higher than the healthcare sector average of 17. It passed 6 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 142.57% in the past year. It has overperformed other stocks in the healthcare sector by 220 percentage points.

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 86, which is 69 points higher than the healthcare sector average of 17. It passed 6 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 55.68% in the past year. It has overperformed other stocks in the healthcare sector by 133 percentage points.

3. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 40 points higher than the healthcare sector average of 17. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -53.56% in the past year. It has overperformed other stocks in the healthcare sector by 24 percentage points.

Are healthcare stocks a good buy now?

59.17% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 40.26% over the next year.

4.04% of healthcare stocks have a Zen Rating of A (Strong Buy), 13.26% of healthcare stocks are rated B (Buy), 48.61% are rated C (Hold), 27.4% are rated D (Sell), and 6.69% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 30.08x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Bausch Health Companies (NYSE:BHC)

3. Bioventus (NASDAQ:BVS)

1. Conmed (NYSE:CNMD)

2. Cumberland Pharmaceuticals (NASDAQ:CPIX)

3. Spok Holdings (NASDAQ:SPOK)

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Embecta (NASDAQ:EMBC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Bausch Health Companies (NYSE:BHC)

3. Bioventus (NASDAQ:BVS)

1. Conmed (NYSE:CNMD)

2. Cumberland Pharmaceuticals (NASDAQ:CPIX)

3. Spok Holdings (NASDAQ:SPOK)

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Embecta (NASDAQ:EMBC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.